The neurotargeting research group has a broad range of expertise. Advances in molecular neurobiology now provide possibilities for the development of new therapies designed for treatment of neurological and psychiatric disorders. This type of translational research requires competency in both basic molecular research and experience in practical treatment.
The Neurotargeting Group constitutes one of three groups/labs in the Basic and Translational Neuroscience unit.
The group involves three principal investigators. Please visit their lab pages to learn more about their research.
